Atopic dermatitis (AD) is a chronic inflammatory disease that can cause pruritic, polymorphic skin lesions. As it is a relapsing disease, treatment aims to alleviate clinical symptoms, eliminate predisposing or exacerbating factors, and reduce flares and comorbidities. Several recent studies have indicated that patients with AD may have a higher risk of developing chronic diseases such as cardiovascular disease compared to non-AD patients. In order to systematically investigate comorbidities and long-term outcomes in AD patients, we will complete this project within 36 months after all the data have been collected. Our project will involve interdisciplinary research teams with epidemiological, clinical, and global health expertise. It is hoped that our findings would help improve the management of AD patients.
